Provided by Tiger Trade Technology Pte. Ltd.

Adaptimmune Therapeutics PLC

0.0549
0.0000
Volume:- -
Turnover:- -
Market Cap:14.55M
PE:-0.08
High:0.0549
Open:0.0549
Low:0.0549
Close:0.0549
52wk High:0.8100
52wk Low:0.0403
Shares:265.05M
Float Shares:183.08M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6574
EPS(LYR):-0.2807
ROE:-1341.10%
ROA:-40.86%
PB:-0.21
PE(LYR):-0.20

Loading ...

Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 30, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Aug 31, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]